Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kristoffer Alexander Zervides"'
Autor:
Kristoffer Alexander Zervides, Shorena Janelidze, Jessika Nystedt, Birgitta Gullstrand, Petra Nilsson, Pia C Sundgren, Anders A Bengtsson, Oskar Hansson, Andreas Jönsen
Publikováno v:
BMC neurology. 22(1)
Background Neuronal damage in systemic lupus erythematosus (SLE) is common, but the extent and mechanisms are unclear. Neurofilament light (NfL) concentrations rise in plasma and cerebrospinal fluid (CSF) during neuronal damage in various neurologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5796684ad2af2ad04e3f4c5a7f77cce
https://pubmed.ncbi.nlm.nih.gov/36494778
https://pubmed.ncbi.nlm.nih.gov/36494778
Autor:
Andreas Jern, Birgitta Gullstrand, Petra Nilsson, Jessica Nystedt, Andreas Jönsen, Kristoffer Alexander Zervides, Anders A. Bengtsson, Pia C. Sundgren
Publikováno v:
Poster presentations.
Background/Purpose Neuropsychiatric (NP) involvement and fatigue are both major problems in SLE. S100A8/A9 is a marker of inflammation, which responds to therapy in SLE patients. S100A8/A9 is expressed in the CNS. We investigated S100A8/A9 in relatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12b470ac328ee522f1ffd62d37281c59
https://doi.org/10.1136/lupus-2020-eurolupus.91
https://doi.org/10.1136/lupus-2020-eurolupus.91
Autor:
Vibe Skov, Hans Carl Hasselbalch, Vardan Nersesjan, Anders Lindholm Sørensen, Lasse Kjær, Kristoffer Alexander Zervides
Publikováno v:
European journal of haematologyREFERENCES. 104(1)
BACKGROUND: Iron deficiency in polycythaemia vera (PV) may impact the validity of the haematocrit (HCT), since HCT is red blood cell count (RBC) × mean corpuscular volume (MCV).OBJECTIVES: To investigate (a) the effect of microcytosis on HCT, (b) th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a855e5886623bba866868bfb0899f687
https://pubmed.ncbi.nlm.nih.gov/31584701
https://pubmed.ncbi.nlm.nih.gov/31584701
Autor:
Peter Tougaard, Kristoffer Alexander Zervides, Anders Elm Pedersen, Søren Skov, Axel Kornerup Hansen
Publikováno v:
Immunopharmacology and immunotoxicology. 38(1)
A number of anti-tumor necrosis factor alpha (TNF-α) biologics have been developed in recent years, such as adalimumab, etanercept, and infliximab for the treatment of chronic inflammatory disorders like rheumatoid arthritis (RA), inflammatory bowel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0459d058bbe0b38a642733a1aff0b02d
https://pubmed.ncbi.nlm.nih.gov/26810853
https://pubmed.ncbi.nlm.nih.gov/26810853